What is the real burden of the overactive bladder? Results from a national prevalence study.
PROMS
overactive bladder
quality of life
Journal
Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
28
11
2021
received:
11
09
2021
accepted:
22
12
2021
pubmed:
3
3
2022
medline:
30
4
2022
entrez:
2
3
2022
Statut:
ppublish
Résumé
To describe the prevalence of overactive bladder determining patient-reported outcome measures (PROMS) and potential risk factors. A cross-sectional population-based study to estimate lower urinary tract symptoms (LUTS) prevalence in the Colombian population was performed (COBaLT study). Overactive bladder (OAB) was assessed using 2002 International Continence Society definitions and the Report on the Terminology for Female Pelvic Floor Dysfunction. PROMS were included to evaluate participant's perceptions of health-related quality of life (QoL). Spanish validated questionnaires were used, including the International Consultation on Incontinence Questionnaire Overactive Bladder (ICIQ-OAB) and Patient Perception of Bladder Condition (PPBC) scale. A total of 1060 individuals were assessed. The mean age of participants was 42.2 years, and most participants were Hispanic (93.15%). The overall prevalence of OAB syndrome was 31.70%, and it was more frequently reported in women than in men (39.25% vs. 24.15%). Most participants with OAB did not perceive their symptoms as bothersome. The most bothersome symptom, associated with moderate/severe impact in QoL was urinary urgency. According to the PPBC questionnaire 75.6% of the participants reported that their bladder condition does not cause any problem, while 11.% reported moderate to severe bother. The multivariable model showed high blood pressure and anxiety were associated with OAB in men. In females, depression, obstructive sleep apnea, IBS, and pelvic organ prolapse were associated with OAB syndrome. Using the symptomatic definition of OAB can overestimate the real impact and burden of the condition, and treatment should be targeted to those symptomatic patients with QoL impairment as they would benefit from further management. The questionnaires seem to overestimate the condition, since we assessed it from a PROMS perspective there is not such a marked QoL impact.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
926-934Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11):1388-1395. doi:10.1111/j.1464-410X.2008.07601.x
Stewart W, Van Rooyen J, Cundiff G. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327-336. doi:10.1007/s00345-002-0301-4
Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int. 2011;108(9):1459-1471. doi:10.1111/j.1464-410X.2010.10013.x
Haylen BT, de Ridder D, Freeman RM. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;798:797-798. doi:10.1002/nau
Irwin DE, Milsom I, Hunskaar S. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306-1315. doi:10.1016/j.eururo.2006.09.019
Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2002;87(9):760-766. doi:10.1046/j.1464-410x.2001.02228.x
Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77(5):1081-1087. doi:10.1016/j.urology.2010.08.039
Safarinejad MR. Prevalence of the overactive bladder among Iranian women based on the International Continence Society definition: a population-based study. Int Urol Nephrol. 2009;41(1):35-45. doi:10.1007/s11255-008-9403-2
Chapple CR, Kelleher CJ, Evans CJ. A narrative review of patient-reported outcomes in overactive bladder: what is the way of the future? Eur Urol. 2016;70(5):799-805. doi:10.1016/j.eururo.2016.04.033
Plata M, Bravo-Balado A, Robledo D. Prevalence of lower urinary tract symptoms and overactive bladder in men and women over 18 years old: the Colombian overactive bladder and lower urinary tract symptoms (COBaLT) study. Neurourol Urodyn. 2019;38(1):200-207. doi:10.1002/nau.23828
Coyne KS, Barsdorf AI, Thompson C. Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS). Neurourol Urodyn. 2012;31(4):448-454. doi:10.1002/nau.21202
Abrams P, Avery K, Gardener N, Donovan J. The international consultation on incontinence modular questionnaire. J Urol. 2006;175(3):1063-1066. doi:10.1016/S0022-5347(05)00348-4
McKown S, Abraham L, Coyne K, Gawlicki M, Piault E, Vats V. Linguistic validation of the N-QOL (ICIQ), OAB-q (ICIQ), PPBC, OAB-S and ICIQ-MLUTSsex questionnaires in 16 languages. Int J Clin Pract. 2010;64(12):1643-1652. doi:10.1111/j.1742-1241.2010.02489.x
Coyne KS, Matza LS, Kopp Z, Abrams P. The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol. 2006;49(6):1079-1086. doi:10.1016/j.eururo.2006.01.007
Gomes CM, Averbeck MA, Koyama M, Soler R. Impact of OAB symptoms on work, quality of life and treatment-seeking behavior in Brazil. Curr Med Res Opin. 2020;36(8):1403-1415. doi:10.1080/03007995.2020.1760806
Bump RC, Mattiasson A, Bø K. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10-17. doi:10.1016/S0002-9378(96)70243-0
Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012;80(1):90-96. doi:10.1016/j.urology.2012.04.004
Vaughan CP, Johnson TM, Ala-Lipasti MA. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study. Eur Urol. 2011;59(4):629-636. doi:10.1016/j.eururo.2011.01.031
Irwin DE, Milsom I, Kopp Z, Abrams P. Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol. 2008;53(5):1029-1039. doi:10.1016/j.eururo.2008.01.027
Soler R, Gomes CM, Averbeck MA, Koyama M. The prevalence of lower urinary tract symptoms (LUTS) in Brazil: results from the epidemiology of LUTS (Brazil LUTS) study. Neurourol Urodyn. 2018;37(4):1356-1364. doi:10.1002/nau.23446
Coyne KS, Payne C, Bhattacharyya SK. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Heal. 2004;7(4):455-463. doi:10.1111/j.1524-4733.2004.74008.x
Wyman JF, Harkins SW, Choi SC, Taylor JR, Fantl JA. Psychosocial impact of urinary incontinence in women. Obstet Gynecol. 1987;70(3 Pt 1):378-381. http://www.ncbi.nlm.nih.gov/pubmed/3627585
Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int. 2003;92(7):731-735. doi:10.1046/j.1464-410X.2003.04463.x
Vrijens D, Drossaerts J, van Koeveringe G, Van Kerrebroeck P, van Os J, Leue C. Affective symptoms and the overactive bladder-a systematic review. J Psychosom Res. 2015;78(2):95-108. doi:10.1016/j.jpsychores.2014.11.019
Nagao Y, Shimizu S, Kurabayashi A. Effects of silodosin and tadalafil on bladder dysfunction in spontaneously hypertensive rats: possible role of bladder blood flow. Int J Urol. 2020;27(3):258-265. doi:10.1111/iju.14171
Akbar A, Liu K, Michos ED. Association of overactive bladder with hypertension and blood pressure control: the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens. 2021;35:22-30. doi:10.1093/ajh/hpaa186
Scheepe JR, Amelink A, de Jong BWD, Wolffenbuttel KP, Kok DJ. Changes in bladder wall blood oxygen saturation in the overactive obstructed bladder. J Urol. 2011;186(3):1128-1133. doi:10.1016/j.juro.2011.04.111
Andersson K-E, Boedtkjer DB, Forman A. The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction. Ther Adv Urol. 2017;9(1):11-27. doi:10.1177/1756287216675778
Hwang EC, Kim SO, Nam DH. Men with hypertension are more likely to have severe lower urinary tract symptoms and large prostate volume. LUTS. 2015;7(1):32-36. doi:10.1111/luts.12046
de Boer TA, Slieker-ten Hove MCP, Burger CW, Vierhout ME. The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population. Int Urogynecol J. 2011;22(5):569-575. doi:10.1007/s00192-010-1323-x
de Boer TA, Salvatore S, Cardozo L. Pelvic organ prolapse and overactive bladder. Neurourol Urodyn. 2010;29(1):30-39. doi:10.1002/nau.20858
Peyronnet B, Mironska E, Chapple C. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75(6):988-1000. doi:10.1016/j.eururo.2019.02.038
Witthaus MW, Nipa F, Yang J-H, Li Y, Lerner LB, Azadzoi KM. Bladder oxidative stress in sleep apnea contributes to detrusor instability and nocturia. J Urol. 2015;193(5):1692-1699. doi:10.1016/j.juro.2014.11.055